Status:
UNKNOWN
Evaluating a Digital Tool for Supporting Breast Cancer Patients
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Collaborating Sponsors:
Innovate UK
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This is a prospective randomised controlled trial that aims to understand the impact of the OWise breast cancer digital tool in newly diagnosed breast cancer patients. Half the patients will receive t...
Eligibility Criteria
Inclusion
- female
- adult (age 18 years or over)
- newly diagnosed
- early breast cancer
- first primary cancer diagnosis
- under treatment at one of the participating sites.
Exclusion
- have started anti-cancer treatment
- private patients
- unable to read or write in English
- significant cognitive impairment
- poor mental health
- do not have access to the internet
- confirmed metastatic disease
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT03866655
Start Date
October 1 2019
End Date
December 30 2022
Last Update
February 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Royal Marsden NHS Foundation Trust
London, United Kingdom, SW9 8LE